Heterogeneous Treatment Effects on Cardiovascular Diseases With Dipeptidyl Peptidase‐4 Inhibitors Versus Sulfonylureas in Type 2 Diabetes Patients
2020 ◽
2020 ◽
2020 ◽
2020 ◽
2018 ◽
Vol 10
(3)
◽
pp. 706-713
◽
2020 ◽
Vol 24
(2)
◽
pp. 143
2020 ◽
2020 ◽
2020 ◽